GLP-1 drugs like Ozempic are associated with a higher risk of developing wet age-related macular degeneration in people with ...

Ashvattha will present Phase 2 data on migaldendranib, a subcutaneous therapy for DME and wet AMD, which could offer a more patient-friendly alternative to current injection-based treatments Company ...

About Wet AMD Wet age-related macular degeneration (wet AMD ... and best-in-class bioerodible Durasert E™ technology. Vorolanib brings a new mechanism of action to the treatment of VEGF-mediated ...

Metallic nanoparticles injected into the retina partly restored vision in blind mice and could work as a treatment for ...

NIH scientists explore a new multi-graft retinal surgery technique to advance cell therapy for treating dry age-related macular degeneration (AMD).

About Wet AMD Wet age-related macular degeneration (wet AMD ... Vorolanib brings a new mechanism of action to the treatment of VEGF-mediated retinal diseases as a potent and highly selective ...

Jay Chhablani, MD, explains how 3D choroidal vessel segmentation transforms ophthalmology, enhancing disease diagnosis and ...

In the last 20 years, there have been rapid advances in the treatment options ... patients with myopic macular degeneration complicated by CNV may benefit from a new ophthalmic frontier of ...

National Institutes of Health (NIH) scientists have developed a new surgical technique ... animals may help advance treatment options for dry age-related macular degeneration (AMD), which is ...

Receiving the SMC recommendation of LYTENAVA™ (bevacizumab gamma) for patients with wet AMD is a significant milestone for our company and a testament to our commitment to improving patient outcomes,” ...

This is also called age-related macular degeneration ... cost than many existing treatments, an initial clinical trial suggests. Researchers have developed a new therapy that can be injected ...